State Of New Jersey Common Pension Fund D Crinetics Pharmaceuticals, Inc. Transaction History
State Of New Jersey Common Pension Fund D
- $24.9 Billion
- Q2 2025
A detailed history of State Of New Jersey Common Pension Fund D transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of New Jersey Common Pension Fund D holds 62,552 shares of CRNX stock, worth $1.68 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
62,552
Previous 55,878
11.94%
Holding current value
$1.68 Million
Previous $1.87 Million
4.06%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding CRNX
# of Institutions
232Shares Held
86.7MCall Options Held
40KPut Options Held
162K-
Vanguard Group Inc Valley Forge, PA9.31MShares$250 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.89MShares$185 Million0.05% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.24MShares$168 Million2.28% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$167 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.11MShares$137 Million0.02% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $1.44B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...